看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
. u t& l; D3 n' E% S1 u9 a
# T" N: }1 ?: j/ S
_ Y# S+ p# {2 z8 K* {! RCurrently available feasibility data for possible combination strategies.
% y+ V7 \$ ?: o' k+ v1 E6 [————————————————————————————————
( b4 X$ c' _$ U( C9 Q5 {# lCombination Feasibility according to preliminary data
: _& B# d3 Y8 R2 L; g7 q3 _9 v——————————————————————————————————
8 q8 X0 a+ O6 t! w- S1 mBevacizumab + sorafenib Yes, reduced dose
T; N6 n8 c+ Y+ SBevacizumab + sunitinib† No
: d6 |1 k4 }$ y2 l- EBevacizumab + temsirolimus Yes
/ Q9 u" X+ q. {# \Bevacizumab + everolimus Yes
8 K3 }: R1 B$ u' ZSorafenib + sunitinib ? ! w" J# k# \' t I: Y$ n' k6 C
Sorafenib + temsirolimus Yes, reduced dose 7 z3 E( r" @; {/ [7 H
Sorafenib + everolimus Yes, reduced dose # U$ r! \! @7 s( k3 T% x
Sunitinib + temsirolimus† No , `) b0 ^: ?) {# h. v( A5 n% ]. k {# S
Sunitinib + everolimus ?
; Y/ ^- Q _+ j& e' \Temsirolimus + everolimus ? , q+ n( l1 E, S5 q* N
————————————————————
' _, d$ K, x0 O6 V1 D$ L†Led to US FDA warning.
- d6 c3 b- J& F9 Z?: As yet unattempted combination.( r' ]4 A" {, X& z
|